-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Provectus Biopharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q3 2025.
- Provectus Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $313K, a 67.1% decline year-over-year.
- Provectus Biopharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $1.28M.
- Provectus Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.28M.
- Provectus Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2016 was $0.000, a 100% decline from 2015.
- Provectus Biopharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2015 was $671K, a 480% increase from 2014.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)